title: Health Canada "passes the buck" on diabetes drug, researcher charges.
authors.forename: Laura
authors.initials: L
authors.lastname: Eggertson
mesh_terms: D002170:Canada; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone